After taking a closer look at industry trends, Cantor Fitzgerald analyst Pablo Zuanic remains "comfortable" recommending shares of Aurora Cannabis (ACB). The analyst thinks the Canadian licensed producer group will re-rate in the year ahead and that headline concerns about oversupply should be put in context. Aurora's gross sales in Canada are second only to those of Canopy Growth (CGC) over the last five reported quarters and that scale advantage will be relevant with the trade becoming more discerning, Zuanic tells investors in a research note. Further, he believes realized net pricing should become a "differentiating factor when determining valuations in the group." Zuanic keeps an Overweight rating on shares of Aurora Cannabis with a C$3.80 price target.